A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
Nebivolol has been studied across 18 research domains including ❤️ Cardiovascular, 🔬 Inflammation, 🧘 Stress & Anxiety, 🔥 Metabolic, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 52% of studies addressing this area.
The following compounds share molecular targets with Nebivolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Nebivolol is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.